---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-232631"
form_type: "8-K"
ticker: "BDSX"
cik: "0001439725"
company_name: "BIODESIX INC"
filed_at: "2026-05-20T20:18:43+00:00"
generated_at: "2026-05-20T21:02:46.016558+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Biodesix shareholders elect directors, approve say-on-pay, ratify KPMG at 2026 annual meeting

## Summary
- Elected Jean Franchi (6.19M for, 0 against, 721.8K abstain) and Hany Massarany (6.85M for, 0 against, 66.2K abstain) as Class III directors until 2029.
- Non-binding advisory vote on named executive officer compensation passed: 6.62M for, 283.5K against, 11.6K abstain.
- Stockholders approved 'one year' frequency for future say-on-pay votes (6.11M for one year, 777.4K for three years).
- Ratified KPMG LLP as independent auditor for 2026: 8.70M for, 59 against, 2,429 abstain.

## SEC filing metadata
- accession: 0001193125-26-232631
- form_type: 8-K
- ticker: BDSX
- cik: 0001439725
- company_name: BIODESIX INC
- filed_at: 2026-05-20T20:18:43+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1439725/000119312526232631/0001193125-26-232631-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1439725/000119312526232631/d103157d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-232631
- JSON: https://secwatch.observer/filing/0001193125-26-232631.json
- Plain text: https://secwatch.observer/filing/0001193125-26-232631.txt

## Key facts
- Shareholder Votes
  BIODESIX INC shareholders approved Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers at the 2026-05-19 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2026-05-19
  source text: At the Annual Meeting, the stockholders approved, on a non-binding advisory basis, the compensation of the Company’s named executive officers by the vote indicated below:
  evidence_url: https://www.sec.gov/Archives/edgar/data/1439725/000119312526232631/0001193125-26-232631-index.htm
- Shareholder Votes
  BIODESIX INC shareholders approved Non-binding advisory vote on the frequency of solicitation of advisory votes to approve named executive officer compensation at the 2026-05-19 meeting.
  - Proposal: say on pay frequency
  - Outcome: passed
  - Meeting: 2026-05-19
  source text: At the Annual Meeting, the stockholders approved, on a non-binding advisory basis, the frequency of solicitation of advisory votes to approve named executive officer compensation by the vote indicated below:
  evidence_url: https://www.sec.gov/Archives/edgar/data/1439725/000119312526232631/0001193125-26-232631-index.htm
- Shareholder Votes
  BIODESIX INC shareholders approved Election of Class III directors at the 2026-05-19 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2026-05-19
  source text: Item 5.07. Submission of Matters to a Vote of Security Holders. Biodesix, Inc. (the “Company”) held its 2026 annual meeting of stockholders (the “Annual Meeting”) on May 19, 2026.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1439725/000119312526232631/0001193125-26-232631-index.htm
- Shareholder Votes
  BIODESIX INC shareholders approved Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026 at the 2026-05-19 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2026-05-19
  source text: At the Annual Meeting, the stockholders ratified the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026 by the vote indicated below:
  evidence_url: https://www.sec.gov/Archives/edgar/data/1439725/000119312526232631/0001193125-26-232631-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.